Skip to main content
LobbyMap

Federal Pharma Capital

Education · Lobbying Client

C
Influence Score
40/100
Moderate Influence
$1.2M
Total Lobby Spend
4
Policy Issues
1
Lobbyists
0
Revolving Door

Federal Pharma Capital reported $1.2 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Education, Science/Technology, Government Issues. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Energy
US House of Representatives
Centers for Medicare & Medicaid Services
Securities & Exchange Commission
Dept of Transportation
Small Business Administration

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarCovington & Burling LLP
APP
1$64K
2020 Apr-JunBrownstein Hyatt LLP
EDUGOV
1$89K
2020 Jul-SepCovington & Burling LLP
GOVAPPSCI
1$70K
2020 Oct-DecSquire Patton Boggs LLP
APPSCIGOV+1
1$64K
2021 Jan-MarAkin Gump LLP
EDU
1$47K
2021 Apr-JunSquire Patton Boggs LLP
EDUSCIAPP
1$54K
2021 Jul-SepK&L Gates LLP
SCI
1$59K
2021 Oct-DecBGR Group LLP
SCIAPP
1$53K

Federal Pharma Capital Lobbying FAQ

Federal Pharma Capital has spent $1.2M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Federal Pharma Capital lobbies on 4 policy issues, including Education, Science/Technology, Government Issues, Apparel/Clothing. These disclosures are filed quarterly with the Senate Office of Public Records.

Federal Pharma Capital has an Influence Score of 40/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Federal Pharma Capital employs 1 registered lobbyists, of whom 0 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Federal Pharma Capital has contacted 6 government entities as part of their lobbying activities, including Dept of Energy, US House of Representatives, Centers for Medicare & Medicaid Services.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.